Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
Purpose: The purpose of our study is to report our experience with the use of certolizumab pegol in patients with refractory non-infectious uveitis. Observations: We present a case series of three patients with non-infectious uveitis, treated with twice-monthly subcutaneous certolizumab pegol. All o...
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Elsevier
2020-06-01
|
| Colecção: | American Journal of Ophthalmology Case Reports |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2451993618301336 |